JP2017526689A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017526689A5 JP2017526689A5 JP2017511914A JP2017511914A JP2017526689A5 JP 2017526689 A5 JP2017526689 A5 JP 2017526689A5 JP 2017511914 A JP2017511914 A JP 2017511914A JP 2017511914 A JP2017511914 A JP 2017511914A JP 2017526689 A5 JP2017526689 A5 JP 2017526689A5
- Authority
- JP
- Japan
- Prior art keywords
- dengue
- composition
- virus
- use according
- serotype
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000025729 dengue disease Diseases 0.000 claims 33
- 241000725619 Dengue virus Species 0.000 claims 24
- 208000001490 Dengue Diseases 0.000 claims 19
- 206010012310 Dengue fever Diseases 0.000 claims 19
- 230000002238 attenuated effect Effects 0.000 claims 14
- 239000000427 antigen Substances 0.000 claims 13
- 102000036639 antigens Human genes 0.000 claims 13
- 108091007433 antigens Proteins 0.000 claims 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 208000009714 Severe Dengue Diseases 0.000 claims 5
- 241000700605 Viruses Species 0.000 claims 3
- 241000710831 Flavivirus Species 0.000 claims 2
- 241000710772 Yellow fever virus Species 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 229940051021 yellow-fever virus Drugs 0.000 claims 2
- 241000710829 Dengue virus group Species 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14306350 | 2014-09-02 | ||
| EP14306350.1 | 2014-09-02 | ||
| EP15305851.6 | 2015-06-04 | ||
| EP15305851 | 2015-06-04 | ||
| PCT/EP2015/070060 WO2016034629A1 (en) | 2014-09-02 | 2015-09-02 | Vaccine compositions against dengue virus diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017526689A JP2017526689A (ja) | 2017-09-14 |
| JP2017526689A5 true JP2017526689A5 (enExample) | 2018-10-11 |
Family
ID=54064325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017511914A Pending JP2017526689A (ja) | 2014-09-02 | 2015-09-02 | デング熱ウイルス病に対するワクチン組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10946087B2 (enExample) |
| EP (1) | EP3188751A1 (enExample) |
| JP (1) | JP2017526689A (enExample) |
| KR (2) | KR20230170812A (enExample) |
| CN (1) | CN106999564A (enExample) |
| AU (1) | AU2015310951A1 (enExample) |
| BR (1) | BR112017004197A2 (enExample) |
| CA (1) | CA2958949A1 (enExample) |
| MX (1) | MX2017002794A (enExample) |
| MY (1) | MY192739A (enExample) |
| PH (1) | PH12017500304A1 (enExample) |
| SG (1) | SG11201701256RA (enExample) |
| TW (1) | TWI852899B (enExample) |
| WO (1) | WO2016034629A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113637086B (zh) | 2013-03-15 | 2024-10-11 | 武田疫苗股份有限公司 | 用于疫苗中的登革热病毒嵌合式构建物的组合物及方法 |
| TWI852899B (zh) | 2014-09-02 | 2024-08-21 | 法商賽諾菲巴斯德公司 | 疫苗組合物 |
| SG10201913383RA (en) | 2016-04-13 | 2020-03-30 | Takeda Vaccines Inc | Compositions and methods of vaccination against dengue virus in children and young adults |
| US11531029B2 (en) | 2017-05-08 | 2022-12-20 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Methods and compositions for the detection of flavivirus infections |
| AU2018346724B2 (en) | 2017-10-05 | 2025-01-09 | Sanofi Pasteur | Compositions for booster vaccination against dengue |
| ES2908304T3 (es) | 2018-09-05 | 2022-04-28 | Takeda Vaccines Inc | Dosis unitaria de vacuna contra el dengue y administración de la misma |
| US11464815B2 (en) * | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| US11426461B2 (en) | 2018-09-05 | 2022-08-30 | Takeda Vaccines, Inc. | Methods for preventing dengue and hepatitis A |
| EP4013451A1 (en) * | 2019-08-16 | 2022-06-22 | Takeda Vaccines, Inc. | Methods for preventing dengue and hepatitis a |
| WO2025072259A1 (en) | 2023-09-25 | 2025-04-03 | Takeda Vaccines, Inc. | Coadministration of tetravalent dengue vaccine with hpv vaccine |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2741077B1 (fr) * | 1995-11-14 | 1998-01-23 | Pasteur Institut | Vaccin polyvalent anti-dengue |
| WO1998037911A1 (en) | 1997-02-28 | 1998-09-03 | Oravax, Inc. | Chimeric flavivirus vaccines |
| US6962708B1 (en) | 1997-02-28 | 2005-11-08 | Acambis, Inc. | Chimeric flavivirus vaccines |
| US7227011B2 (en) | 1998-06-04 | 2007-06-05 | United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Nucleic acid vaccines for prevention of flavivirus infection |
| AU1813901A (en) | 1999-12-01 | 2001-06-12 | Oravax, Inc | Chimeric flavivirus vaccines |
| CA2941182A1 (en) | 2000-02-16 | 2001-08-23 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Avirulent, immunogenic flavivirus chimeras |
| EP1401859B1 (en) | 2001-06-01 | 2013-08-07 | Sanofi Pasteur Biologics Co. | Chimeric flavivirus vectors |
| CN103555669B (zh) | 2002-01-15 | 2017-10-13 | 赛诺菲巴斯德生物制剂有限责任公司 | 黄病毒疫苗 |
| US20050002968A1 (en) | 2002-01-15 | 2005-01-06 | Monath Thomas P. | Flavivirus vaccines |
| US20040259224A1 (en) | 2002-05-31 | 2004-12-23 | Farshad Guirakhoo | Tetravalent Dengue vaccines |
| BRPI0613328A2 (pt) | 2005-06-17 | 2011-01-04 | Sanofi Pasteur | cepa do vìrus da dengue-1 vivo atenuado, composição imunogênica, composição de vacina, ácido nucléico isolado, poliproteìna isolada e fragmento de poliproteìna |
| ATE475706T1 (de) | 2005-06-17 | 2010-08-15 | Sanofi Pasteur | Abgeschwächter dengue-serotyp-2-stamm |
| KR101357685B1 (ko) | 2005-11-21 | 2014-02-06 | 사노피 파스퇴르 리미티드 / 사노피 파스퇴르 리미떼 | 재조합 바이러스용 안정화 제형 |
| CU23586A1 (es) | 2005-11-22 | 2010-10-30 | Ct Ingenieria Genetica Biotech | Métodos y proteínas para el tratamiento profiláctico y/o terapéutico de los cuatro serotipos del virus de dengue y otros flavivirus |
| US7968102B2 (en) | 2006-01-13 | 2011-06-28 | Sanofi Pasteur S.A. | Dengue chimeric viruses |
| FR2903605A1 (fr) | 2006-07-12 | 2008-01-18 | Sanofi Pasteur Sa | Methode d'immunisation contre les quatres serotypes de la dengue |
| FR2906724B1 (fr) | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
| FR2909286B1 (fr) | 2006-12-01 | 2012-06-08 | Sanofi Pasteur | Methode d'immunisation contre les 4 serotypes de la dengue |
| US8591916B2 (en) | 2007-01-31 | 2013-11-26 | Sanofi Pasteur Biologics, Llc | Flavivirus vaccine vector against influenza virus |
| BRPI0913012B1 (pt) | 2008-04-30 | 2021-12-14 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Quimera de ácido nucleico, métodos para detectar um anticorpo do vírus da dengue em uma amostra de um paciente, e para produzir partículas virais que expressam proteínas prm e e do vírus da dengue, uso de vírus codificado pela quimera e flavivírus ou partícula viral quiméricos |
| EP2143440A1 (fr) | 2008-07-09 | 2010-01-13 | Sanofi Pasteur | Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués |
| US8968996B2 (en) * | 2009-06-01 | 2015-03-03 | Takeda Vaccines, Inc. | Compositions and methods for rapid immunization against dengue virus |
| KR20140015127A (ko) | 2009-07-29 | 2014-02-06 | 베른드 헬무트 아담 렘 | 폴리머 입자 및 이의 용도 |
| EP2353609A1 (en) | 2010-02-04 | 2011-08-10 | Sanofi Pasteur | Immunization compositions and methods |
| US8993744B2 (en) * | 2010-05-21 | 2015-03-31 | University of Pittsburgh—of the Commonwealth System of Higher Education | Universal dengue virus sequences and methods of use |
| WO2012051491A1 (en) | 2010-10-14 | 2012-04-19 | The United States Of America, As Represented By The Secretary National Institutes Of Health | Compositions and methods for controlling neurotropic viral pathogenesis by micro-rna targeting |
| ITMI20121231A1 (it) * | 2012-07-16 | 2014-01-17 | St Microelectronics Srl | Metodo di controllo burst-mode per basso consumo in ingresso in convertitori risonanti e relativo dispositivo di controllo |
| AU2013295014B2 (en) | 2012-07-24 | 2018-01-18 | Sanofi Pasteur | Vaccine compositions |
| PE20150356A1 (es) * | 2012-07-24 | 2015-03-20 | Sanofi Pasteur | Composiciones de vacuna para la prevencion contra la infeccion por el virus del dengue |
| TWI852899B (zh) | 2014-09-02 | 2024-08-21 | 法商賽諾菲巴斯德公司 | 疫苗組合物 |
| WO2017005654A1 (en) * | 2015-07-03 | 2017-01-12 | Sanofi Pasteur | Concomitant dengue, diphtheria, tetanus, whooping cough (pertussis), polio, and haemophilus influenzae type b vaccination. |
-
2015
- 2015-09-01 TW TW104128945A patent/TWI852899B/zh active
- 2015-09-02 CN CN201580046426.3A patent/CN106999564A/zh active Pending
- 2015-09-02 MX MX2017002794A patent/MX2017002794A/es unknown
- 2015-09-02 JP JP2017511914A patent/JP2017526689A/ja active Pending
- 2015-09-02 SG SG11201701256RA patent/SG11201701256RA/en unknown
- 2015-09-02 MY MYPI2017700549A patent/MY192739A/en unknown
- 2015-09-02 CA CA2958949A patent/CA2958949A1/en active Pending
- 2015-09-02 EP EP15759746.9A patent/EP3188751A1/en not_active Withdrawn
- 2015-09-02 KR KR1020237042016A patent/KR20230170812A/ko active Pending
- 2015-09-02 WO PCT/EP2015/070060 patent/WO2016034629A1/en not_active Ceased
- 2015-09-02 BR BR112017004197A patent/BR112017004197A2/pt not_active Application Discontinuation
- 2015-09-02 AU AU2015310951A patent/AU2015310951A1/en not_active Abandoned
- 2015-09-02 US US15/507,952 patent/US10946087B2/en active Active
- 2015-09-02 KR KR1020177008402A patent/KR20170043660A/ko not_active Ceased
-
2017
- 2017-02-17 PH PH12017500304A patent/PH12017500304A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017526689A5 (enExample) | ||
| JP2015524421A5 (enExample) | ||
| Yong et al. | Recent advances in the vaccine development against Middle East respiratory syndrome-coronavirus | |
| JP2019151636A5 (enExample) | ||
| JP2015524422A5 (enExample) | ||
| RU2017113571A (ru) | Рекомбинантные вакцины от fmdv и их применение | |
| MX2013004159A (es) | Proteina vp6 de la capside de norovirus y de rotavirus para el uso como vacuna combinada. | |
| JP2016508999A5 (enExample) | ||
| JP2017502662A5 (enExample) | ||
| WO2017156511A8 (en) | Live attenuated zika virus vaccine | |
| Pripuzova et al. | Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy | |
| WO2013001285A3 (en) | Fmdv vp1 peptides | |
| JP2013523783A5 (enExample) | ||
| JP2019511221A5 (enExample) | ||
| JP2016504315A5 (enExample) | ||
| JP2018500878A5 (enExample) | ||
| CO6541529A2 (es) | Método, plasmideo y composición para inducir una respuesta inmune contra virus de la dengue basado en vacunas de adn y virus quimericos | |
| Umar et al. | Emerging threat of H9N2 viruses in poultry of Pakistan and vaccination strategy | |
| MX2022000718A (es) | Vacuna en vector recombinante de adenovirus aviar serotipo 9. | |
| JP2016528176A5 (enExample) | ||
| WO2014140166A3 (en) | Vaccine | |
| Zhang et al. | Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71 | |
| WO2018066999A3 (en) | Chimeric enterovirus virus-like particles | |
| Kim et al. | Cross-protective immune responses elicited by a Korean variant of infectious bronchitis virus | |
| BR112012029633A2 (pt) | vetores do parapoxvírus contendo antígeno do vírus da raiva. |